Initial Statement of Beneficial Ownership (3)
July 02 2015 - 3:41PM
Edgar (US Regulatory)
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0104
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Batycky Richard P.
|
2. Date of Event Requiring Statement (MM/DD/YYYY)
6/9/2015
|
3. Issuer Name
and
Ticker or Trading Symbol
ACORDA THERAPEUTICS INC [ACOR]
|
(Last)
(First)
(Middle)
420 SAW MILL RIVER ROAD
|
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
_____ Director
_____ 10% Owner
___
X
___ Officer (give title below)
_____ Other (specify below)
Chief Tech. Off. & Site Head /
|
(Street)
ARDSLEY, NY 10502
(City)
(State)
(Zip)
|
5. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_
X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Beneficially Owned
|
1.Title of Security
(Instr. 4)
|
2. Amount of Securities Beneficially Owned
(Instr. 4)
|
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
|
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
|
Common Stock
|
47979
(1)
|
D
|
|
Table II - Derivative Securities Beneficially Owned (
e.g.
, puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 4)
|
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
|
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
|
4. Conversion or Exercise Price of Derivative Security
|
5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
|
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
|
Date Exercisable
|
Expiration Date
|
Title
|
Amount or Number of Shares
|
Employee Stock Option (right to buy)
|
(2)
|
10/22/2024
|
Common Stock
|
26750
|
$32.27
|
D
|
|
Employee Stock Option (right to buy)
|
(2)
|
10/29/2024
|
Common Stock
|
73250
|
$35.88
|
D
|
|
Employee Stock Option (right to buy)
|
(3)
|
3/4/2025
|
Common Stock
|
5546
|
$35.74
|
D
|
|
Explanation of Responses:
|
(
1)
|
Restricted stock issued under the Company's 2006 Employee Incentive Plan.
25,000 of these shares will vest 25% every year for four years with vest dates of October 22, 2015, October 22, 2016, October 22, 2017, and October 22, 2018.
22,000 of these shares will vest over three years, with 20% vesting on November 7, 2015, 30% vesting on November 7, 2016, and the remaining 50% vesting on November 7, 2017.
979 of these shares will vest 25% every year for four years with vest dates of December 1, 2015, December 1, 2016, December 1, 2017, and December 1, 2018.
|
(
2)
|
Twenty-five percent of the shares subject to this option will vest on October 22, 2015. The balance of the shares subject to this option will vest in equal quarterly installments over the three years thereafter.
|
(
3)
|
The shares subject to this option vest in equal quarterly installments over four years beginning on January 1, 2015 with the first quarterly installment vesting on April 1, 2015.
|
Reporting Owners
|
Reporting Owner Name / Address
|
Relationships
|
Director
|
10% Owner
|
Officer
|
Other
|
Batycky Richard P.
420 SAW MILL RIVER ROAD
ARDSLEY, NY 10502
|
|
|
Chief Tech. Off. & Site Head
|
|
Signatures
|
/s/ Richard P. Batycky
|
|
7/2/2015
|
**
Signature of Reporting Person
|
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
|
*
|
If the form is filed by more than one reporting person,
see
Instruction 5(b)(v).
|
**
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
Note:
|
File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure.
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
|
Acorda Therapeutics (NASDAQ:ACOR)
Historical Stock Chart
From Mar 2024 to Apr 2024
Acorda Therapeutics (NASDAQ:ACOR)
Historical Stock Chart
From Apr 2023 to Apr 2024